These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8364473)

  • 1. Sensitive determination of ambenonium in plasma using inhibitory activity to acetylcholinesterase.
    Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1993 Mar; 16(3):280-3. PubMed ID: 8364473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of tolerance in the increase of contractile muscle tension by ambenonium in rats.
    Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1994 Jul; 17(7):944-7. PubMed ID: 8000383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
    Hodge AS; Humphrey DR; Rosenberry TL
    Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of ambenonium in biological samples by reversed-phase ion-pair liquid chromatography.
    Yamamoto K; Kohda Y; Saitoh Y; Nakagawa F
    J Chromatogr; 1988 Dec; 433():167-76. PubMed ID: 3235545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
    Yamamoto K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ambenonium chloride in dogs after intravenous and oral administration.
    Tharasse-Bloch C; Chabenat C; Boucly P; Boismare F; Marchand J
    Arzneimittelforschung; 1989 Feb; 39(2):257-8. PubMed ID: 2730696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats.
    Yamamoto K; Kohda Y; Sawada Y; Iga T
    Biopharm Drug Dispos; 1991 Nov; 12(8):613-25. PubMed ID: 1801966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1985 Mar; 232(3):732-40. PubMed ID: 2857786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylcholinesterase inhibitors on the metabolism of amyloid precursor protein in vitro.
    Pakaski M; Papp H; Rakonczay Z; Fakla I; Kasa P
    Neurobiology (Bp); 2001; 9(1):55-7. PubMed ID: 11558939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interaction of reversible inhibitors with the catalytic centers and allosteric sites of cholinesterases].
    Tonkopiĭ VD; Prozorovskiĭ VB; Suslova IM
    Biull Eksp Biol Med; 1976 Aug; 82(8):947-50. PubMed ID: 1026294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of cholinesterases measured fluorometrically.
    Siegel GJ; Lehrer GM; Silides D
    J Histochem Cytochem; 1966 Jun; 14(6):473-8. PubMed ID: 5963519
    [No Abstract]   [Full Text] [Related]  

  • 12. A radiometric microassay of acetylcholinesterase.
    Potter LT
    J Pharmacol Exp Ther; 1967 Jun; 156(3):500-6. PubMed ID: 6028877
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of pH and reversible inhibitors on decarbamylation of acetylcholinesterase].
    Kugusheva LI; Rozengart VI; Sherstobitov OE
    Ukr Biokhim Zh (1978); 1991; 63(3):29-35. PubMed ID: 1926583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive determination of ambenonium chloride in serum from patients with myasthenia gravis using ion-exchange resin extraction and reversed-phase ion-pair chromatography.
    Ohtsubo K; Higuchi S; Aoyama T; Fujii N; Goto I
    J Chromatogr; 1989 Nov; 496(2):397-406. PubMed ID: 2613842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of inclusion complex of cyclodextrin with ambenonium to improve the treatment of anticholinesterase poisoning.
    Yudin MA; Ivanov IM; Nikiforov AS; Kornyukhina TM; Tyunin MA
    Bull Exp Biol Med; 2013 Jun; 155(2):218-20. PubMed ID: 24130994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of four cholinesterase inhibitors in rats.
    Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1995 Sep; 18(9):1292-5. PubMed ID: 8845827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chlorcholin chloride and N,N-dimethyl-(2-bromethyl)-hydrazinium bromide on the activity of cholinesterases in the erythrocytes and plasma of rat and man].
    Henninghausen G; Tiefenbach B; Karnstedt U; Kröning G
    Acta Biol Med Ger; 1973; 31(6):873-8. PubMed ID: 4791181
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
    Tunek A; Svensson LA
    Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of sarin in the blood plasma of the rat.
    Polak RL; Cohen EM
    Biochem Pharmacol; 1970 Mar; 19(3):877-81. PubMed ID: 5507692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.